| Literature DB >> 34126972 |
Imen Rejeb1, Mouna Jerbi2,3,4, Houweyda Jilani5,4, Hanène Gaied2,3,4, Yasmina Elaribi5,4, Syrine Hizem5,4, Raja Aoudia3,4,6, Hafedh Hedri3,4,6, Chiraz Zaied7, Salwa Abid7, Hassen Bacha7, Taieb BenAbdallah4,6, Lamia BenJemaa5,4, Rim Goucha2,3,4.
Abstract
BACKGROUND: Karyomegalic interstitial nephritis (KIN) is a rare disease entity first described by Burry in 1974. The term KIN was introduced by Mihatsch et al. in 1979. KIN is characterized by chronic tubulointerstitial nephritis associated with enlarged tubular epithelial cell nuclei, which leads to a progressive decline of renal function. The prevalence of this disease is less than 1% of all biopsies, and its pathogenesis is unclear. KIN results from mutations in FAN1 (FANCD2/FANCI-Associated Nuclease 1), a gene involved in the DNA damage response pathway, particularly in the kidney. In this study, we report two Tunisian consanguineous families with KIN caused by mutations in the FAN1 gene.Entities:
Keywords: Chronic tubulointerstitial nephritis; FAN1 gene; Frameshift variants; Karyomegalic interstitial nephritis
Mesh:
Year: 2021 PMID: 34126972 PMCID: PMC8201669 DOI: 10.1186/s12920-021-01009-7
Source DB: PubMed Journal: BMC Med Genomics ISSN: 1755-8794 Impact factor: 3.063
Fig. 1a Pedigree of the family A, b Pedigree of the family Z
Fig. 2Renal histology in Patient IV-7 and Patient IV-12 in family A. a Renal biopsy, Masson’s trichroma (magnification × 400). Proximal tubules with giant nuclei, irregular nuclear membrane (Patient IV-7). b Renal biopsy, hematoxylin and eosine stain (magnification × 200). Giant nuclei with irregular nuclear membrane (Patient IV-7). c, d Renal biopsy, electron microscopy. Giant karyomegalic nuclei with irregular nuclear membrane (Patient IV-7). e Renal biopsy, electron microscopy. Giant karyomegalic nuclei of epithelial cells of proximal tubules (Patient IV-12)
Clinical and biological findings of patients with KIN in families A and Z
| Patient No | Sexe | AN | AERSD | Smoking | Personal history | Cause of renal examination | HMG | TR | Death | Initial creatinine (µmol/l) | eGFR ml/min/1.73m2 | Cytolisis | Cholestasis | VST | KB | Liver Biopsy | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Family A | IV-2 | M | 36 | 36 | No | 0 | Convulsion | 0 | Yes | No | 900 | 9.9 | Yes | Yes | – | No | No |
| IV-7 | M | 39 | 43 | Yes | Appendectomy | Donor check up | 0 | Yes | Yes | 161 | 69.4 | No | Yes | – | Yes K + | Yes K- | |
| IV-11 | M | 26 | 29 | No | 0 | Donor Check up | 0 | No | Yes | 197 | 53.38 | Yes | Yes | – | No | No | |
| IV-12 | M | 32 | 38 | No | Urethritis | Donor Check up | 0 | No | No | 141 | 65.9 | Yes | Yes | – | Yes K + | No | |
| Family Z | II-2 | M | 31 | 36 | No | 0 | Fortuitously | 0 | Yes | Yes | 1000 | ND | No | No | – | No | No |
| II-3 | M | 25 | 33 | No | Epilepsy and visceral leishmaniasis | Donor check up | 0 | No | No | 200 | ND | No | No | – | Yes K + | Yes K- |
AN, age at the time of the discovery of nephropathy; AERSD, Age at the time of the end of renal stage disease; HMG, hepatomegaly; TR, transplantation; eGFR, estimated glomerular filtration rate; VST, viral serology test; KB, Kidney biopsy; K, Karyomegaly; + , present; -, absent; ND, no data
Fig. 3Renal histology in Patient II 3 in family Z. a Renal biopsy, Masson’s trichroma (magnification × 200).Giant nuclei of tubular epithelium. b Renal biopsy, Masson’s trichroma (magnification × 400). Giant nuclei of tubular epithelium, moderately inflammatory interstitial fibrosis. c Renal biopsy. Hematoxylin and eosine stain (magnification × 200). Karyomegalic nephropathy. d Renal biopsy. Masson’strichroma (magnification × 400). Normal glomerulus
Fig. 4I: Electropherogram showing the mutation c.2616delA found in family A (a, c mutation found in patient IV-2, b, d wildtype). II: Electropherogram showing the mutation c.2603delT found in family Z (a, c wildtype, b, d mutation found in patient II-3)
Review of mutations reported in the FAN1 gene
| References | Ethnic origin | Nucleotide alteration | Deduced protein change | Exon/intron (state) | Parental consan-guinity |
|---|---|---|---|---|---|
| Zhou et al. [ | French | c.1234 + 2T>A c.2036_7delGA | Splice site p.Arg679Thrfs*5 | 2 (het) 7 (het) | No |
| Zhou et al. [ | French | c.1234 + 2T>A c.2245C>T | Splice site p.Arg749* | 2 (het) 9 (het) | No |
| Zhou et al. [ | French | c.1375 + 1G>A c.2616delA | Splice site p.Asp873Thrfs*17 | 3 (het) 12 (het) | No |
| Zhou et al. [ | German | c.1606C>T c.2786A>C | p.Arg536* p.Gln929Pro | 5 (het) 12 (het) | No |
| Zhou et al. [ | German | c.1606C>T c.2878G>A | p.Arg536* p.Asp960Asn | 5 (het) 13 (het) | No |
| Zhou et al. [ | New Zealand Maori | c.2120G>A | p.Trp707* | 8 (hom) | distant? |
| Zhou et al. [ | Spanish | c.2616delA | p.Asp873Thrfs*17 | 12 (hom) | No |
| Zhou et al. [ | Swiss | c.2611T>C c.2878G>A | p.Cys871Arg p.Asp960Asn | 12 (het) 13 (het) | No |
| Zhou et al. [ | USA | c.2774_5delTT c.2810G>A | p.Leu925Profs*25 p.Gly937Asp | 12 (het) 13 (het) | No |
| Isnard et al. [ | French | c.2616delA | p.Asp873Thrfs*17 | 12 (hom) | ND |
| Dash et al. [ | Bulgarian | c.1102C>T c.2616delA | p.Gln368* p.Asp873Thrfs*17 | 2 (het) 12 (het) | ND |
| Koshy et al. [ | Indian | c.1356T>G c.1369C>T | p.Asn452Lys p.Gln457* | 4(het) 4 (het) | ND |
| Present study Family A | Tunisian | c.2616delA | p.Thr872Thrfs*17 | 12 (hom) | Yes |
| Present study Family Z | Tunisian | c.2603delT | p.Leu868Argfs*21 | 12(hom) | Yes |
Hom, homozygous; Het, heterozygous; ND, no data